| BENZENEAZOMALONONITRILE |
苯基偶氮丙二腈 |
6017-21-6 |
| 1-Cyclohexylpiperazine |
1-环己基哌嗪 |
17766-28-8 |
| 4-(4-Chloro-2-thienyl)-2-thiazolamine |
4-(4-氯-2-噻吩基)-2-噻唑胺 |
570407-10-2 |
| 4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine |
4-(4-氯噻吩-2-基)-5-(4-环己基哌嗪-1-基)噻唑-2-胺 |
570407-42-0 |
| Capmatinib hydrochloride |
盐酸卡玛替尼一水合物 |
1865733-40-9 |
| 2-Chloro-4-methylpyrimidine |
2-氯-4-甲基嘧啶 |
13036-57-2 |
| (Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate |
非奈利酮中间体 |
1050477-39-8 |
| Dabrafenib Mesylate(GSK-2118436B) |
达帕菲尼甲磺酸盐 |
1195768-06-9 |
| Dabrafenib |
达拉非尼 |
1195765-45-7 |
| Methyl 3-{[(2,6-difluoropheyl)sulfonyl]aMino}-2-fluorabenzoate |
达拉菲尼中间体3 |
1195768-19-4 |
| 1-cyclohexylpiperazine hydrochloride |
1-环己基哌嗪盐酸盐 |
245487-40-5 |
| tert-butyl 4-cyclohexylpiperazine-1-carboxylate |
4-环己基哌嗪-1-甲酸叔丁酯 |
1224935-95-8 |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate |
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate |
1050477-43-4 |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate |
非奈利酮中间体 |
1050477-44-5 |
| Avatrombopag Impurity 22 |
阿伐曲波帕杂质22 |
570403-14-4 |
| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid |
非奈利酮中间体 |
1050477-45-6 |
| 1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione |
1-[2-氯-1-羟基-3-(6-喹啉基)丙基]-2,5-吡咯烷二酮 |
1197377-31-3 |
| Axitinib Impurity B |
阿昔替尼杂质B |
944835-85-2 |
| 5-chloro-6-[4-(ethoxycarbonyl)piperidino]nicotinic acid |
6-(4-(乙氧基羰基)哌啶-1-基)-5-氯吡啶-3-羧酸 |
931395-73-2 |
| [[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester |
[[(1R)-2-(6-氨基-9H-嘌呤-9-基)-1-甲基乙氧基]甲基]磷酸单苯酯 |
379270-35-6 |
QQ
微信
